Showing 1 - 2 results of 2 for search 'Ronald Goldwater', query time: 0.01s Refine Results
  1. 1
    A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055

    A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055 by Xiao-Hong Zhou, Susanne Prothon, Engin Liathdale, Nicola Ferrari, Kebria Hezaveh, Zhi Liu, Szilard Nemes, Joachim Almquist, Michael L. Williams, Olami Sobande, Christer Gottfridsson, Bernadette R. Gochuico, Adam Platt, Zach Brohawn, Maria G. Belvisi, Ronald Goldwater, Ellinor Hornberg, Caroline A. Owen

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans

    A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans by Brian Finan, Jonathan D. Douros, Ronald Goldwater, Ann Maria Kruse Hansen, Julie B. Hjerpsted, Karina Rahr Hjøllund, Martin K. Kankam, Patrick J. Knerr, Anish Konkar, Stephanie A. Mowery, Timo D. Müller, John Rømer Nielsen, Sune Boris Nygård, Diego Perez-Tilve, Kirsten Raun, Bin Yang, Matthias H. Tschöp, Richard D. DiMarchi

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: